does medicaid cover glp 1 Navigating Changes to GLP-1 Medication Coverage MCT2D | 2023 Updates to
Description
In terms of study subjects, the focus was on patients with T2DM, T2DM patients complicated with cardiovascular diseases, or animal models of diabetes-related heart diseases
doi: 10.1186/1475-2840-12-53
Strategies for Minimizing Muscle Loss during Use of Incretin-mimetic Drugs for Treatment of Obesity
T2DM patients are often accompanied by other comorbidities and need to take multiple drugs at the same time
The same has not been clearly shown for cholesterol
None of the drugs yet have clinical trials with more than 2-year follow-up which leaves us with questions as to micronutrient deficiencies and risk of loss of muscle mass and bone density
